Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 101 - 125 av 125 resultater
Tid
Selskap
Tittel
Sektor
Kategori
26 Apr 2021
08:00 CEST
BIOPHYTIS
Biophytis Gives Operational Perspectives on its Sarconeos (BIO101) Ahead of its Upcoming AGM on April 26, 2021
20103010 Biotechnology
Legal
07 Jul 2017
20:24 CEST
BIOPHYTIS
Biophytis annonce l’émission d’une tranche d’ORNANEBSA d’un montant de 3,0 M€
Biotechnology
Corporate life
07 Jul 2017
20:23 CEST
BIOPHYTIS
Biophytis announces the issuance of a €3 million tranche of ORNANEBSA
Biotechnology
Corporate life
15 Jun 2017
18:07 CEST
BIOPHYTIS
BIOPHYTIS selects SGS Life Science Services to conduct MACA-PK, clinical study of Macuneos in dry AMD
Biotechnology
Corporate life
15 Jun 2017
18:06 CEST
BIOPHYTIS
BIOPHYTIS sélectionne SGS Life Science Services pour conduire MACA-PK, étude clinique de Macuneos dans la DMLA sèche
Biotechnology
Corporate life
16 May 2017
08:00 CEST
BIOPHYTIS
Biophytis announces the issuance of a €3 million tranche of ORNANEBSA *
Biotechnology
-
16 May 2017
08:00 CEST
BIOPHYTIS
Biophytis annonce l’émission d’une tranche d’ORNANEBSA d’un montant de 3,0 M€
Biotechnology
-
11 May 2017
08:15 CEST
BIOPHYTIS
Biophytis : Recrutement du premier patient aux Etats-Unis de l’étude SARA-OBS dans la Sarcopénie
Biotechnology
-
11 May 2017
08:14 CEST
BIOPHYTIS
Biophytis : First patient-in in the United States and opening of 2 clinical centers for the SARA-OBS study on Sarcopenia
Biotechnology
Corporate life
03 May 2017
18:36 CEST
BIOPHYTIS
BIOPHYTIS confirme que Sarconeos module le système Rénine- Angiotensine et agit sur le métabolisme musculaire dans l’étude clinique SARA-PK
Biotechnology
Corporate life
03 May 2017
18:35 CEST
BIOPHYTIS
BIOPHYTIS confirms that Sarconeos modulates the Renin-Angiotensin System and activates muscular metabolism in the SARA-PK clinical trial
Biotechnology
Corporate life
27 Apr 2017
18:56 CEST
BIOPHYTIS
BIOPHYTIS : Résultats Annuels 2016
Biotechnology
Income
27 Apr 2017
18:55 CEST
BIOPHYTIS
BIOPHYTIS: 2016 Full Year Results
Biotechnology
Income
04 Apr 2017
07:15 CEST
BIOPHYTIS
Biophytis sécurise le financement de son étude clinique de phase 2b dans la sarcopénie SARA-INT
Biotechnology
-
04 Apr 2017
07:15 CEST
BIOPHYTIS
Biophytis secures funding for phase 2B clinical trial in Sarcopenia, SARA-INT
Biotechnology
-
27 Mar 2017
08:00 CEST
BIOPHYTIS
Biophytis opens the first clinical centers in Europe and starts the recruitment of sarcopenic patients for SARA-OBS study
Biotechnology
-
27 Mar 2017
08:00 CEST
BIOPHYTIS
Biophytis ouvre les premiers centres cliniques en Europe et démarre le recrutement des patients sarcopéniques pour l'étude SARA-OBS
Biotechnology
-
21 Mar 2017
18:00 CET
BIOPHYTIS
BIOPHYTIS : Quatre travaux scientifiques sélectionnés pour présentation à l’International Conference on Frailty & Sarcopenia Research (ICFSR) à Barcelone
Biotechnology
-
21 Mar 2017
18:00 CET
BIOPHYTIS
BIOPHYTIS to present four scientific studies at the International Conference on Frailty & Sarcopenia Research (ICFSR) in Barcelona
Biotechnology
-
01 Mar 2017
18:00 CET
BIOPHYTIS
Biophytis: Full results of SARA-PK study confirm Sarconeos’ good pharmacokinetic profile in elderly patients
Biotechnology
-
01 Mar 2017
18:00 CET
BIOPHYTIS
Biophytis : Les résultats de l’étude SARA-PK confirment le bon profil pharmacocinétique de Sarconeos chez le sujet âgé.
Biotechnology
-
21 Feb 2017
18:00 CET
BIOPHYTIS
Biophytis relocates to Pierre and Marie Curie University (UPMC) campus and solidifies creation of leading translational platform for age-related disease
Biotechnology
-
21 Feb 2017
18:00 CET
BIOPHYTIS
Biophytis emménage au sein de l’Université Pierre et Marie Curie (Paris) et développe sa plateforme de recherche sur les maladies du vieillissement
Biotechnology
-
05 Jan 2017
18:09 CET
BIOPHYTIS
BIOPHYTIS to participate to the JP Morgan Annual Healthcare Conference in San Francisco, January 9-12th 2017
Biotechnology
Corporate life
05 Jan 2017
18:08 CET
BIOPHYTIS
BIOPHYTIS participe à la JP Morgan Healthcare Conference du 9 au 12 janvier prochain à San Francisco
Biotechnology
Corporate life
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
1
2
3
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva